Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung‐Hung Su, Jia‐Horng Kao, Lein‐Ray Mo et al.|Liver International|2016Cited by 221
ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent mannerFat‐Moon Suk, Yu‐Chih Liang|Scientific Reports|2018Cited by 91
Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinomaFat‐Moon Suk, Yi‐Jen Liao|Scientific Reports|2019Cited by 33
The Antihistamine Deptropine Induces Hepatoma Cell Death through Blocking Autophagosome-Lysosome FusionYu‐Chih Liang, Fat‐Moon Suk|Cancers|2020Cited by 30
Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expressionFat‐Moon Suk, Yu‐Chih Liang|Oncotarget|2015Cited by 26